Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02733289

Standard Follow-up Program Cervix Cancer (SFP CERVIX)

Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

Female

Study type

Observational

Primary location

University Medical Center Groningen

Groningen, Netherlands

Location status: Recruiting

Location contact

Jannet Beukema

CONTACT

[email protected]

+31503610025

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Every cervical cancer patient with curative intent for radiotherapy, treated at our department

Exclusion criteria

  • Non-curative treatment
  • Part of the treatment is given in another hospital

Treatment and study plan

Primary outcomes

  1. Complications

    Time frame: Five years

    Physiological parameters, questionnaires

Study contacts

Contact information is provided by the study sponsor or research team.

Jannet Beukema

CONTACT

[email protected]

+31503610025

Petra Veldhuijzen van Zanten

CONTACT

[email protected]

+31503614659

Sponsors and collaborators

Lead sponsor

University Medical Center Groningen

Other

Registry information

Acronym: SFPCERVIX

Important dates

Study start
2015
Primary completion
2040
Study completion
2040
First posted
Apr 11, 2016
Registry last updated
Feb 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.